Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Bjermer

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
Allergy|May 20, 2020
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREASven F Seys, Shana De Bont, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2024
Exploring Definitions and Predictors of Response to Biologics for Severe AsthmaGhislaine Scelo, Trung N Tran, Tham T Le, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Frontiers in Immunology|May 7, 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthmaCeleste M Porsbjerg, John Townend, Celine Bergeron, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Clinical and Translational Allergy|June 17, 2021
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergyJean Bousquet, Oliver Pfaar, Ioana Agache, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
Allergy|May 20, 2020
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREASven F Seys, Shana De Bont, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 20, 2024
Exploring Definitions and Predictors of Response to Biologics for Severe AsthmaGhislaine Scelo, Trung N Tran, Tham T Le, et al.
Journal of Asthma and Allergy|October 28, 2022
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic TherapyWenjia Chen, Mohsen Sadatsafavi, Trung N Tran, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
Allergy|March 17, 2023
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for bothPaul E Pfeffer, Nasloon Ali, Ruth Murray, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 10, 2023
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma RegistryWenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Frontiers in Immunology|May 7, 2024
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthmaCeleste M Porsbjerg, John Townend, Celine Bergeron, et al.
The World Allergy Organization Journal|June 17, 2025
Biomarker profile and disease burden associated with intermittent and long-term oral corticosteroid use in patients with severe asthma prior to biologic initiation in real-life (STAR)Florence Schleich, Désirée Larenas-Linnemann, Alan Altraja, et al.
Clinical and Translational Allergy|June 17, 2021
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergyJean Bousquet, Oliver Pfaar, Ioana Agache, et al.
Pageof 28